HRS-7450 Injection Phase II Clinical Trial for Acute Ischemic Stroke.

Summary

This study plans to enroll a total of 208 patients with Acute Ischemic Stroke (AIS) who present within 4.5 to 24 hours of symptom onset and meet the specified imaging criteria.

Timeline

Start

2025-10-31

Primary completion

2026-10

Completion

2027-01

Drugs

Indications